David J. Calkins, PhD, is recognized for ground-breaking contributions to the field of vision research.
Research to Prevent Blindness and Aerie Pharmaceuticals are partnering to provide grant opportunities to support novel research in glaucoma.
Donald Zack, MD, PhD, is recognized for ground-breaking contributions to the field of vision research.
The Career Advancement Awards—one focused specifically on glaucoma research—support novel science related to eye diseases by up-and-coming researchers.
The Glaucoma Foundation and Research to Prevent Blindness have partnered to provide five fellowships in 2021 to increase innovation and diversity in glaucoma research.
RPB grantees provide expert advice on glaucoma in the first event of the "Lunch & Learn" series.
The RPB-supported researchers hope their finding will lead to tests to identify cell damage before irreversible vision loss.
Dr. David Beebe's studies of the vitreous body - the gel that fills the eye - are aimed at identifying the mechanism responsible for age-related nuclear cataracts and open angle glaucoma.
Compared to earlier generations, today's generation has a 50% reduced probability of losing sight to glaucoma 20 years after a diagnosis, according to research supported by RPB.Read the story.Read the...
Routine screening of older African Americans for glaucoma -- a high-risk group -- would significantly reduce the incidence of blindness at relatively low cost, RPB researchers report in a recently published...
Scientists have designed and tested a pressure-sensing contact lens that will, in the future, allow glaucoma patients to monitor their eye pressure at home, providing more detailed and continuous information in...